TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 141 filers reported holding TG THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $253,000 | -12.8% | 6,525 | +8.3% | 0.06% | -18.3% |
| Q1 2021 | $290,000 | -10.2% | 6,025 | -2.9% | 0.07% | -16.5% |
| Q4 2020 | $323,000 | +86.7% | 6,205 | -64.6% | 0.08% | +30.8% |
| Q1 2020 | $173,000 | -18.0% | 17,550 | -7.5% | 0.06% | -12.2% |
| Q4 2019 | $211,000 | +88.4% | 18,975 | -4.8% | 0.07% | +105.6% |
| Q3 2019 | $112,000 | -36.4% | 19,940 | -1.7% | 0.04% | -35.7% |
| Q2 2019 | $176,000 | +31.3% | 20,290 | +21.9% | 0.06% | +47.4% |
| Q1 2019 | $134,000 | +94.2% | 16,640 | -1.5% | 0.04% | +46.2% |
| Q4 2018 | $69,000 | -65.8% | 16,890 | -53.1% | 0.03% | -62.3% |
| Q3 2018 | $202,000 | -57.8% | 35,990 | -1.2% | 0.07% | -62.7% |
| Q2 2018 | $479,000 | -1.4% | 36,440 | +6.5% | 0.18% | -3.6% |
| Q1 2018 | $486,000 | – | 34,225 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |